Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TGFBR1 | P36897 | 20/20 | 0.77 |
| ▸ | KDR | P35968 | 7/20 | 0.77 |
| ▸ | MAPK14 | Q16539 | 5/20 | 0.69 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20074376 | 0.90 | TGFBR1 (0.73) | TGFBR1KDRMAPK14 | |
| SCHEMBL21733992 | 0.89 | TGFBR1 (0.83) | TGFBR1KDRMAPK14 | |
| SCHEMBL21268631 | 0.89 | TGFBR1 (0.80) | TGFBR1KDRMAPK14 | |
| SCHEMBL21277834 | 0.88 | TGFBR1 (0.85) | TGFBR1KDRMAPK14 | |
| SCHEMBL20074554 | 0.87 | TGFBR1 (1.00) | TGFBR1KDRMAPK14 | |
| SCHEMBL20074553 | 0.87 | TGFBR1 (1.00) | TGFBR1KDRMAPK14 | |
| SCHEMBL20074556 | 0.87 | TGFBR1 (1.00) | TGFBR1KDRMAPK14 | |
| SCHEMBL20074436 | 0.86 | TGFBR1 (0.72) | TGFBR1KDRMAPK14 | |
| SCHEMBL20074374 | 0.86 | TGFBR1 (1.00) | TGFBR1KDRMAPK14 | |
| SCHEMBL20074444 | 0.86 | TGFBR1 (0.78) | TGFBR1KDRMAPK14 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3527570-A1 | FIVE-MEMBERED HETEROARYL RING BRIDGED RING DERIVATIVE, PREPARATION METHOD THEREFOR AND MEDICAL USE THEREOF | Jiangsu Hengrui Medicine Co., Ltd. (CN) | 2019-08-21 | — | — | EP | disclosed |
| WO-2018068759-A1 | FIVE-MEMBERED HETEROARYL RING BRIDGED RING DERIVATIVE, PREPARATION METHOD THEREFOR AND MEDICAL USE THEREOF | 江苏恒瑞医药股份有限公司 | 2018-04-19 | — | — | WO | disclosed |